Product analysis
SAMe 200 mg offers a straightforward way to take SAMe for its role in normal metabolism, with clear labeling that makes comparisons easier.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The SAMe form is clearly identified. Its name alone does not establish how well it is absorbed or a quality advantage.
Ingredient Transparency100
Both the SAMe amount and form are stated. That makes it easier to identify what you are buying and compare servings.
Value For Money40
The cost relative to the active amount offers modest value. Clear labeling helps with price comparisons, but does not establish that the serving will deliver a particular benefit.
Customer Satisfaction85
Customer feedback is very positive across several thousand ratings. The broad response supports an established picture of satisfaction, without proving liver benefits.
Product Focus72
The single-ingredient formula is linked to liver support through SAMe’s role in metabolism. Findings from a different regimen in people with liver disease do not establish routine toxin removal from this serving.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.32
- Also available
SAMe 200 mg$18.00- Customer rating
- 4.6 · 3,128 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
SAMe (S-Adenosyl-L-Methionine Disulfate Tosylate) | 200 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability77
Stabilized Salt Form
Packaging Integrity
Dose, Safety & Label Transparency60
Active Dosage Strength
Net SAMe Yield Transparency
Value40
Price Per 400mg Active Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
- Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
- S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
- Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection.
- S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.